Keith Katkin Emergent Bio Solutions Inc. (EBS) insider trading activity

Keith Katkin is Director of Emergent BioSolutions Inc.. Currently has a direct ownership of 59,872 shares of EBS, which is worth approximately $343,066. The most recent transaction as insider was on May 23, 2024, when has been sold 17,430 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.9K

0% 3M change

41.07% 12M change

Total Value Held $343,066

Keith Katkin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
May 23 2024	BUY Grant, award, or other acquisition	-	17,430 Added 22.55%	59,872 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	33,847 Added 44.37%	42,442 Common Stock
Apr 02 2022	BUY Grant, award, or other acquisition	-	8,595 Added 50.0%	8,595 Common Stock

Also insider at

SNDX

Syndax Pharmaceuticals Inc Healthcare

RIGL

RIGEL PHARMACEUTICALS INC Healthcare

Director

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

Keith Katkin

Director

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS

Account